a:head closes another 7-digit EUR financing round

February 22nd, 2021|media|

After securing more than EUR 4 million of private and public funding in 2019, a:head today closed another 7-digit EUR equity round with a consortium of investors including red data AG, the company’s seed investor.

a:head launched to transform CNS drug discovery

August 7th, 2019|media|

a:head bio AG, an Austrian biotech company focusing on the development of next generation therapeutics for the treatment of brain disorders based on human cerebral organoids has recently been incorporated.